clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Achlorhydria D000126 1 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Angina Pectoris D000787 27 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Bacterial Infections D001424 21 associated lipids
Bacteriuria D001437 7 associated lipids
Barrett Esophagus D001471 3 associated lipids
Bartonella Infections D001474 3 associated lipids
Body Weight D001835 333 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bradycardia D001919 13 associated lipids
Bronchial Spasm D001986 18 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchitis D001991 6 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Chlamydia Infections D002690 7 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Colitis D003092 69 associated lipids
Confusion D003221 4 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Conjunctivitis, Bacterial D003234 3 associated lipids
Cross Infection D003428 9 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Cysts D003560 4 associated lipids
Dermatitis, Exfoliative D003873 10 associated lipids
Drug Eruptions D003875 30 associated lipids
Dermatomycoses D003881 17 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diarrhea D003967 32 associated lipids
Diphtheria D004165 2 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Duodenitis D004382 4 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Dyspepsia D004415 5 associated lipids
Dyspnea D004417 10 associated lipids
Ecchymosis D004438 3 associated lipids
Empyema D004653 3 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Walkey AJ and Wiener RS Macrolide antibiotics and survival in patients with acute lung injury. 2012 Chest pmid:22116799
Park SJ et al. Fulminant and Fatal Multiple Organ Failure in a 12-Year-Old Boy With Mycoplasma pneumoniae Infection. 2012 Allergy Asthma Immunol Res pmid:22211173
Falkinham JO et al. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria. 2012 Tuberculosis (Edinb) pmid:22209468
Nseir W et al. Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study. 2012 Aliment. Pharmacol. Ther. pmid:22646167
Zaater MF et al. Determination and stability assessment of clarithromycin in human plasma using RP-LC with electrochemical detection. 2012 J Chromatogr Sci pmid:22647394
Choi HS et al. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. 2012 World J. Gastroenterol. pmid:22654429
Majima Y et al. Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp. 2012 Auris Nasus Larynx pmid:21636230
Nujić K et al. Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities. 2012 Eur. J. Pharmacol. pmid:22209877
Hiramatsu M et al. Risk factors that affect the surgical outcome in the management of focal bronchiectasis in a developed country. 2012 Ann. Thorac. Surg. pmid:22119119
Koh WJ et al. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. 2012 Am. J. Respir. Crit. Care Med. pmid:22878282
Maurer FP et al. Acquisition of clarithromycin resistance mutations in the 23S rRNA gene of Mycobacterium abscessus in the presence of inducible erm(41). 2012 J. Antimicrob. Chemother. pmid:22833642
Togami K et al. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. 2012 Pharmazie pmid:22764569
Fujioka T et al. A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan. 2012 J. Gastroenterol. pmid:22065160
Park HG et al. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. 2012 Aliment. Pharmacol. Ther. pmid:22066530
Chung JW et al. Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance. 2012 J. Gastroenterol. Hepatol. pmid:21793912
Erol E et al. Antibiotic susceptibility patterns of Crossiella equi and Amycolatopsis species causing nocardioform placentitis in horses. 2012 J. Vet. Diagn. Invest. pmid:23051830
Dalkmann P et al. Accumulation of pharmaceuticals, Enterococcus, and resistance genes in soils irrigated with wastewater for zero to 100 years in central Mexico. 2012 PLoS ONE pmid:23049795
Kurugol Z et al. Severe Hemolytic Anemia Associated with Mild Pneumonia Caused by Mycoplasma pneumonia. 2012 Case Rep Med pmid:23049568
Deng ZH et al. Influence of Helicobacter pylori infection on ghrelin levels in children. 2012 World J. Gastroenterol. pmid:23049220
Malfertheiner P et al. Helicobacter pylori: clinical management. 2012 Curr. Opin. Gastroenterol. pmid:23010682
Tepes B et al. Treatment of Helicobacter pylori infection 2012. 2012 Helicobacter pmid:22958154
Spyridaki A et al. Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. 2012 Antimicrob. Agents Chemother. pmid:22564837
Cajigas-Pezo D et al. [Swelling of right knee in an immunologically compromised patient]. 2012 Enferm. Infecc. Microbiol. Clin. pmid:22521279
McCallum GB et al. Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. 2012 Cochrane Database Syst Rev pmid:23235681
Boyanova L et al. Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study. 2012 J. Med. Microbiol. pmid:21873378
Yoon JH et al. Trends in the eradication rates of Helicobacter pylori infection for eleven years. 2012 World J. Gastroenterol. pmid:23236238
Kotsaki A and Giamarellos-Bourboulis EJ Emerging drugs for the treatment of sepsis. 2012 Expert Opin Emerg Drugs pmid:22780561
Kurinčič M et al. Epigallocatechin gallate as a modulator of Campylobacter resistance to macrolide antibiotics. 2012 Int. J. Antimicrob. Agents pmid:22999765
Fiorini G et al. Newer agents for Helicobacter pylori eradication. 2012 Clin Exp Gastroenterol pmid:22767998
Whittemore KR and Cohen M Imaging and review of a large pre-auricular pilomatrixoma in a child. 2012 World J Radiol pmid:22761984
Kudo T et al. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study. 2012 Helicobacter pmid:22759327
Roccarina D et al. Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication. 2012 Dig Liver Dis pmid:22743557
Tursi A et al. Efficacy and tolerability of a third-line, levofloxacin-based, 10-day sequential therapy in curing resistant Helicobacter pylori infection. 2012 J Gastrointestin Liver Dis pmid:22720300
Giguère S et al. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi. 2012 Vet. Microbiol. pmid:22704561
Burt HJ et al. Progress curve mechanistic modeling approach for assessing time-dependent inhibition of CYP3A4. 2012 Drug Metab. Dispos. pmid:22621802
Lismond A et al. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium. 2012 Int. J. Antimicrob. Agents pmid:22245497
Bermudez LE et al. Identification of (+)-erythro-mefloquine as an active enantiomer with greater efficacy than mefloquine against Mycobacterium avium infection in mice. 2012 Antimicrob. Agents Chemother. pmid:22615290
Agarwal E et al. Efficacy of local drug delivery of 0.5% clarithromycin gel as an adjunct to non-surgical periodontal therapy in the treatment of current smokers with chronic periodontitis: a randomized controlled clinical trial. 2012 J. Periodontol. pmid:22248223
Khan A et al. Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. 2012 World J. Gastroenterol. pmid:22611319
Szałek E et al. Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? 2012 Pharmacol Rep pmid:23406766
Takeshima F et al. Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy. 2012 Intern. Med. pmid:22333383
Brereton AS and El Teraifi H Mycobacterium malmoense: dissemination causes a popliteal aneurysm in a 74-year-old man. 2012 BMJ Case Rep pmid:22602841
Lawal TO et al. Combination studies of Eucalyptus torelliana F. Muell. leaf extracts and clarithromycin on Helicobacter pylori. 2012 Phytother Res pmid:22318891
Slater CM and Ford AC Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305216
Gatta L et al. Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305217
Dicicco M et al. Efficacy of clarithromycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermedius. 2012 BMC Vet. Res. pmid:23171620
Graham DY and Trespalacios AA Treatment of Helicobacter pylori in Latin America. 2012 Lancet pmid:22305218
Alfakry H et al. The association of serum neutrophil markers and acute coronary syndrome. 2012 Scand. J. Immunol. pmid:22537345
Shaifali I et al. Antibiotic susceptibility patterns of urinary pathogens in female outpatients. 2012 N Am J Med Sci pmid:22536558
Gisbert JP Rescue Therapy for Helicobacter pylori Infection 2012. 2012 Gastroenterol Res Pract pmid:22536225
Lee RP et al. Mycobacterium chelonae infection after total knee arthroplasty: a case report. 2012 J Orthop Surg (Hong Kong) pmid:22535831
Shaaban HS et al. Mycobacterium chelonae infection of the parotid gland. 2012 J Glob Infect Dis pmid:22529633
Fakheri H et al. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial. 2012 Helicobacter pmid:22221615
Georgopoulos S et al. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece. 2012 Helicobacter pmid:22221616
Senhorinho GN et al. Occurrence and antimicrobial susceptibility of Porphyromonas spp. and Fusobacterium spp. in dogs with and without periodontitis. 2012 Anaerobe pmid:22609780
Komatsu S et al. Clarithromycin enhances bortezomib-induced cytotoxicity via endoplasmic reticulum stress-mediated CHOP (GADD153) induction and autophagy in breast cancer cells. 2012 Int. J. Oncol. pmid:22200786
Matsuzaki J et al. Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies. 2012 Antimicrob. Agents Chemother. pmid:22203601
Kobashi Y et al. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period. 2012 J. Infect. Chemother. pmid:22205543
Lin Z and Will Y Evaluation of drugs with specific organ toxicities in organ-specific cell lines. 2012 Toxicol. Sci. pmid:22166485
Onoe H et al. Buruli ulcer accompanied by pain in a Japanese patient. 2012 J. Dermatol. pmid:22168180
Peters J et al. Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals. 2012 Drug Metab. Dispos. pmid:22170330
Lulitanond A et al. Prevalence of β-lactamase-negative ampicillin-resistant haemophilus influenzae isolated from patients of a teaching hospital in Thailand. 2012 Jpn. J. Infect. Dis. pmid:22446118
Liang Y et al. Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. 2012 J. Med. Microbiol. pmid:22442290
Gomez-Abreo D et al. [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. 2012 Rev Mal Respir pmid:22440310
Guillot S et al. Macrolide-resistant Bordetella pertussis infection in newborn girl, France. 2012 Emerging Infect. Dis. pmid:22608348
Lee JH et al. A nanohybrid system for taste masking of sildenafil. 2012 Int J Nanomedicine pmid:22619517
Kongchayanun C et al. Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand. 2012 Helicobacter pmid:22759328
Nguyen TV et al. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. 2012 Helicobacter pmid:22759333
Hirata Y et al. Sitafloxacin resistance in Helicobacter pylori isolates and sitafloxacin-based triple therapy as a third-line regimen in Japan. 2012 Int. J. Antimicrob. Agents pmid:22321702
Nizič T et al. Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin. 2012 Wien. Klin. Wochenschr. pmid:22760494
Yokota S et al. Clarithromycin suppresses human respiratory syncytial virus infection-induced Streptococcus pneumoniae adhesion and cytokine production in a pulmonary epithelial cell line. 2012 Mediators Inflamm. pmid:22761540
Brown-Elliott BA et al. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. 2012 Clin. Microbiol. Rev. pmid:22763637
Pereyre S et al. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. 2012 Emerging Infect. Dis. pmid:22305177
Butler CC et al. Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. 2012 BMJ pmid:22302780
Carlos CA et al. Mycobacterial infection identified with broad-range PCR amplification and suspension array identification. 2012 J. Cutan. Pathol. pmid:22764735
Anand TD et al. Superantigen profiles of emm and emm-like typeable and nontypeable pharyngeal streptococcal isolates of South India. 2012 Ann. Clin. Microbiol. Antimicrob. pmid:22296671
Tonkic A et al. Time trends of primary antibiotic resistance of Helicobacter pylori isolates in Southern Croatia. 2012 J Chemother pmid:22759765
Correia M et al. Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization. 2012 PLoS ONE pmid:22529974
Lopes R et al. [Antibiomania: a case of a manic episode induced by clarithromycin]. 2011 Sep-Oct Acta Med Port pmid:22525636
Yasar KK et al. Successfully treated Mycobacterium abscessus mastitis: a rare cause of breast masses. 2011 Oct-Dec Indian J Med Microbiol pmid:22120809
Eisig JN et al. Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. 2011 Oct-Dec Arq Gastroenterol pmid:22147131
Abadi AT et al. High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. 2011 Nov-Dec Saudi J Gastroenterol pmid:22064338
Bilgili SG et al. Phototoxic dermatitis due to Chenopodium album in a child. 2011 Nov-Dec Pediatr Dermatol pmid:21854411
Lee CY et al. Digoxin toxicity precipitated by clarithromycin use: case presentation and concise review of the literature. 2011 Nov-Dec Can J Cardiol pmid:21907534
Zeng M et al. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. 2011 Nov-Dec Am J Rhinol Allergy pmid:22185725
Mello CF and Negra MD Impact of macrolide therapy on mortality of HIV-infected patients with community-acquired pneumonia in a tertiary teaching hospital. 2011 May-Jun Braz J Infect Dis pmid:21670928
Schmidt D [The choice of treatment in HP associated ulcer: metronidazole or amoxicillin--nothing else!]. 2011 May 4-10 Lakartidningen pmid:21809531
Steyaert S et al. Soft tissue infections with atypical mycobacteria in two patients with inflammatory rheumatic diseases using TNF-inhibitors and/or leflunomide. 2011 Mar-Apr Acta Clin Belg pmid:21630616
Söderberg KC and Böttiger Y [Difficult choice between clarithromycin and metronidazole in polyneuropathy]. 2011 Mar 9-15 Lakartidningen pmid:21744557
Chung JW et al. The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea. 2011 Jan-Feb Hepatogastroenterology pmid:21510323
Galmés-Truyols A et al. An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy. 2011 Aug-Sep Enferm. Infecc. Microbiol. Clin. pmid:21684045
Cisarò F et al. Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment. 2011 Panminerva Med pmid:21659979
Cardoso AM et al. In Vitro Antimicrobial Susceptibility of Mycobacterium massiliense Recovered from Wound Samples of Patients Submitted to Arthroscopic and Laparoscopic Surgeries. 2011 Minim Invasive Surg pmid:22110914
Girish C and Balakrishnan S Ceftaroline fosamil: A novel anti-Methicillin-resistant Staphylococcus aureus cephalosporin. 2011 J Pharmacol Pharmacother pmid:21897727
Iskandar I and Walters JD Clarithromycin accumulation by phagocytes and its effect on killing of Aggregatibacter actinomycetemcomitans. 2011 J. Periodontol. pmid:20932153
Karczewska E et al. Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. 2011 Pharmacol Rep pmid:21857091
Urgesi R et al. Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients. 2011 Can. J. Gastroenterol. pmid:21766091
File TM et al. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia. 2011 J. Antimicrob. Chemother. pmid:21482566
Rodríguez-Rodríguez CE et al. Solid-phase treatment with the fungus Trametes versicolor substantially reduces pharmaceutical concentrations and toxicity from sewage sludge. 2011 Bioresour. Technol. pmid:21376580
Andreassen TN et al. Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients. 2011 Eur. J. Clin. Pharmacol. pmid:21140139